<DOC>
	<DOCNO>NCT00541437</DOCNO>
	<brief_summary>To evaluate efficacy safety type 2 diabetes patient switch sulfonylurea co-administered metformin glyburide/metformin combination tablet . It expect safety efficacy GlucoMet® inferior co-administration sulfonylurea metformin .</brief_summary>
	<brief_title>Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin Glyburide/Metformin Combination Tablet</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Male female age 20 75 year diagnose type2 DM minimum 4 month baseline . Maintain stable dose sulfonylurea metformin coadministered 4 month baseline . Consider suitable switch current therapeutic dose one eight test regimen . FPG 80200mg/dl screen visit 6.5 % ≦ HbA1c ≦ 9 % screen visit , change HbA1c ≦ 1 % within 12 week screen visit . The body index must 18.5 35 Kg/m2 screen visit . Sign date Informed Consent Form Renal disease renal dysfunction ( e.g . serum creatinine &gt; 1.5mg/dl ) Currently significant GI disorder ( peptic ulcer diarrhea require chronic medical treatment ) may interfere absorption study drug . History concurrent liver disease hepatic impairment ( total bilirubin upper normal limit , ALT AST 2.5 time upper normal limit screen visit . ) Acute chronic metabolic acidosis , include lactic acidosis , diabetic ketoacidosis , without coma . History cardiovascular collapse ( shock ) congestive heart failure ( function class III IV ) . History stroke , myocardial infarction , coronary revascularization , arrhythmia require medical treatment , within past 6 month . Having proliferative retinopathy . Current acute infection , include systemic infection fever and/or sepsis , pulmonary infection , cellulitis , etc . Having treat insulin past 6 month , treat acarbose glitazones change daily dose past 4 month . Seriously dehydrate . History alcoholism ( time shortterm heavy drinking ) drug abuse , take investigational drug . Pregnant breast feed woman plan pregnancy . Having surgery within 4 week prior enter study history cancer within five year . Known hypersensitive glyburide metformin hydrochloride . Any clinical condition significant concurrent disease judge investigator complicate evaluation study treatment .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Change baseline HbA1c 16 week treatment</keyword>
	<keyword>Change baseline FPG 16 week treatment</keyword>
	<keyword>Change baseline diabetes self-care scale patient drug administration 16 week treatment</keyword>
</DOC>